
Validea's guru fundamental report indicates that Johnson & Johnson (JNJ) receives its highest rating (85%) from their Shareholder Yield Investor model, based on Meb Faber's strategy, which focuses on companies returning cash to shareholders through dividends, buybacks, and debt paydown. While the report highlights that JNJ passes tests for net payout yield, quality/debt, valuation, and relative strength, it fails the specific shareholder yield test, suggesting mixed signals regarding the company's alignment with Faber's strategy despite the overall positive rating.
Johnson & Johnson (JNJ) has received an 85% rating from Validea's Shareholder Yield Investor model, which is based on Meb Faber's strategy emphasizing companies that return cash to shareholders through dividends, buybacks, and debt paydown. This score, exceeding the 80% threshold, typically signifies that the strategy has some interest in the stock. JNJ passed several key criteria within this model, including 'Net Payout Yield', 'Quality and Debt', 'Valuation', and 'Relative Strength', indicating positive underlying fundamentals and a reasonable valuation from the model's perspective. However, a notable discrepancy exists as JNJ specifically 'fails' the overarching 'Shareholder Yield' test itself. This suggests that while JNJ's activities related to dividends and share repurchases (covered under 'Net Payout Yield') meet the model's criteria, its performance concerning net debt paydown, or the aggregate of all three cash return mechanisms, does not align with the specific quantitative thresholds set by Faber's 'Shareholder Yield' definition, despite the otherwise favorable assessment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.65
Ticker Sentiment